- Amazon canceled a pharmaceutical license application in Maine, RBC analysts said.
- It is unclear how this impacts Amazon's health-care plans.
- Since Maine does not require a medical device license for the sale of medical supplies, this may be an indication Amazon may not enter the drug supply chain, RBC analysts said.
Jose Luis Pelaez | Getty Images
Amazon appears to have canceled a pharmaceutical wholesaler application in the state of Maine, analysts at RBC Capital Markets pointed out Tuesday, raising further questions about the tech giant's plans to enter the pharmacy space.
The Maine Board of Pharmacy website shows an application from Amazon.com was canceled on Dec. 1, RBC analysts George Hill, Stephen Hagan and Lee Lueder wrote in a research note. Amazon didn't immediately respond to a request for comment.